The two main ones include: (i) sequencing of key DNA repair genes, such as BRCA1, BRCA2 or PALB2, to identify pathogenic variants, both germline and somatic (14), (ii) quantifying HRD-associated genomic features in tumor DNA (15–17), with often these two combined (18, 19). Here, BRCA1 is linked to neoplasm.